Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stock market
Biotech
Sana stock price triples after allogeneic cell therapy data drop
The data “pave the way for a potentially transformative cure,” for the 1.7 million Americans with type 1 diabetes, Citi analysts wrote Jan. 8.
Gabrielle Masson
Jan 8, 2025 10:38am
ReNeuron leaving AIM exchange after missing fundraising goal
Aug 30, 2024 10:30am
Why do so many biotechs face being kicked off the Nasdaq?
Mar 14, 2023 9:55am
BridgeBio fears biotech markets may stay 'pretty bad' until 2024
May 24, 2022 8:37am
Ginkgo bowled over as short seller dubs it 'a hoax for the ages'
Oct 6, 2021 3:03pm
Cassava CEO blames short sellers for data woes
Sep 3, 2021 8:28am